FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| Nubratori Inc. | 71300-6555 | 71300-6555-1 | Dexamethasone sodium phosphate and Lidocaine HCl | DEXAMETHASONE SODIUM PHOSPHATE AND LIDOCAINE HCL | 3.33 mg/1 mL; 6.67 mg/1 mL | 2026-1 | valid | 2026-09-18 | |
| Nubratori Inc. | 028707055 | 71300-6555 | 71300-6555-1 | Dexamethasone Sodium Phosphate; Lidocaine Hydrochloride | 3.33 mg/1 mL; 6.67 mg/1 mL | 2025-2 | valid | 2026-10-06 | |
| Nubratori Inc. | 71300-6555 | 71300-6555-1 | Dexamethasone sodium phosphate and Lidocaine HCl | DEXAMETHASONE SODIUM PHOSPHATE AND LIDOCAINE HCL | 3.33 mg/1 mL; 6.67 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| Nubratori Inc. | 028707055 | 71300-6555 | 71300-6555-1 | Dexamethasone Sodium Phosphate; Lidocaine Hydrochloride | 3.33 mg/1 mL; 6.67 mg/1 mL | 2025-1 | valid | 2026-10-06 | |
| Nubratori Inc. | 71300-6555 | 71300-6555-1 | Dexamethasone sodium phosphate and Lidocaine HCl | DEXAMETHASONE SODIUM PHOSPHATE AND LIDOCAINE HCL | 3.33 mg/1 mL; 6.67 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Nubratori Inc. | 028707055 | 71300-6555 | 71300-6555-1 | Dexamethasone Sodium Phosphate; Lidocaine Hydrochloride | 3.33 mg/1 mL; 6.67 mg/1 mL | 2024-2 | valid | 2026-10-06 | |
| Nubratori Inc. | 71300-6555 | 71300-6555-1 | Dexamethasone sodium phosphate and Lidocaine HCl | DEXAMETHASONE SODIUM PHOSPHATE AND LIDOCAINE HCL | 3.33 mg/1 mL; 6.67 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Nubratori Inc. | 028707055 | 71300-6555 | 71300-6555-1 | Dexamethasone Sodium Phosphate; Lidocaine Hydrochloride | 3.33 mg/1 mL; 6.67 mg/1 mL | 2024-1 | valid | 2026-10-06 | |
| Nubratori Inc. | 028707055 | 71300-6555 | 71300-6555-1 | Dexamethasone Sodium Phosphate; Lidocaine Hydrochloride | 3.33 mg/1 mL; 6.67 mg/1 mL | 2023-2 | valid | 2026-10-06 | |
| "Nubratori, Inc(028707055)" | 71300-6555 | 71300-6555-1 | Dexamethasone Sodium Phosphate; Lidocaine Hydrochloride | 3.33 mg/1 mL; 6.67 mg/1 mL | 2023-1 | valid | 2026-10-06 | ||
| "Nubratori, Inc(028707055)" | 71300-6555 | 71300-6555-1 | Dexamethasone Sodium Phosphate; Lidocaine Hydrochloride | 3.33 mg/1 mL; 6.67 mg/1 mL | 2022-2 | valid | 2026-10-06 | ||
| "Nubratori, Inc(028707055)" | 71300-6555 | 71300-6555-1 | Dexamethasone Sodium Phosphate; Lidocaine Hydrochloride | 3.33 mg/1 mL; 6.67 mg/1 mL | 2022-1 | valid | 2026-10-06 | ||
| "Nubratori, Inc(028707055)" | 71300-6555 | 71300-6555-1 | Dexamethasone Sodium Phosphate; Lidocaine Hydrochloride | 3.33 mg/1 mL; 6.67 mg/1 mL | 2021-2 | valid | 2026-10-06 | ||
| "Nubratori, Inc(028707055)" | 71300-6555 | 71300-6555-1 | Dexamethasone Sodium Phosphate; Lidocaine Hydrochloride | 3.33 mg/1 mL; 6.67 mg/1 mL | 2021-1 | valid | 2026-10-06 | ||
| "Nubratori, Inc(028707055)" | 71300-6555 | 71300-6555-1 | Dexamethasone Sodium Phosphate; Lidocaine Hydrochloride | 3.33 mg/1 mL; 6.67 mg/1 mL | 2020-2 | valid | 2026-10-06 | ||
| "Nubratori, Inc(028707055)" | 71300-6555 | 71300-6555-1 | Dexamethasone Sodium Phosphate; Lidocaine Hydrochloride | 3.33 mg/1 mL; 6.67 mg/1 mL | 2020-1 | valid | 2026-10-06 | ||
| "Nubratori, Inc(028707055)" | 71300-6555 | 71300-6555-1 | Dexamethasone Sodium Phosphate; Lidocaine Hydrochloride | 3.33 mg/1 mL; 6.67 mg/1 mL | 2019-2 | valid | 2026-10-06 |